BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 20, 2000

View Archived Issues

Infertility induced by immunization against zona pellucida protein in vivo

Read More

Licensing opportunity from NIH: smad3 protein inhibition to enhance wound healing

Read More

Licensing opportunity from NIH: chimeric viruses as vaccine candidates

Read More

FDA approves IND for Indena/Bayer anticancer compound

Read More

Cell Therapeutics seeks European approval of Trisenox

Read More

E.C. approves Roche's CellCept for prevention of liver transplant rejection

Read More

Allergan returns rBPI ophthalmic rights to Xoma

Read More

Immune Network begins DAD2000 Alzheimer's disease trial

Read More

Bexxar BLA filing accepted by FDA

Read More

Ceramide analogue with promising pharmacological profile presented at recent cancer symposium

Read More

RPR-116258A: results from phase I program discussed at NCI-EORTC-AACR

Read More

Y-27632 explored as vasodilator for HF

Read More

Panacea begins preclinical studies with PAN-346 for brain cancers

Read More

Highly lipophilic silatecans highlighted at AAPS and NCI-EORTC-AACR meetings

Read More

Procyon BioPharma and Biovation finalize monoclonal antibody collaboration

Read More

U.K. research leads to orally active, nonestrogenic steroid sulfatase inhibitors for breast cancer

Read More

ET-1 antisense ODNs show antiarrhythmic effects in AMI

Read More

Further clinical data on BMS-232632, presented at AIDS congress, support use in combination therapy

Read More

MCI-154 shown to increase myofilament cooperativity

Read More

Profile of tipranavir indicates suitability for inclusion in combination antiretroviral regimens

Read More

Xanthine-based inhibitors of IL-12 signaling patented by Cell Therapeutics

Read More

Triarylimidazoles synthesized at SmithKline Beecham active as inhibitors of TGF-beta signaling

Read More

AstraZeneca presents new P2X7 receptor antagonists and their potential use

Read More

Novel thrombin inhibitor prodrugs for oral administration

Read More

Potential new treatments for urinary incontinence described by Sanofi-Synthelabo

Read More

New erythromycin derivatives exert potent antimycobacterial activity

Read More

Recently issued patent covers Meiji Seika's new lipid-lowering agents

Read More

New ultrasound contrast agent PB-127 in development for myocardial imaging

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 8, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • Rendering of a key measles protein targeted by neutralizing human antibodies

    First measles treatment advances as vaccination rates drop

    BioWorld
    Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
  • Close up of bow of cruise ship

    Hantavirus is ‘sentinel’ more than acute pandemic threat

    BioWorld
    News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
  • Infensa Bioscience identifies new ASIC blockers

    BioWorld Science
    Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing